When you think of antidepressants, you might picture Prozac or Zoloft—but before those, there was Imipramine, the first tricyclic antidepressant ever developed, approved in the 1950s for treating depression. Also known as Tofranil, it didn’t just treat symptoms—it changed how doctors understood mood disorders. Before Imipramine, depression was often seen as a moral failing or a sign of weakness. This drug proved it had a biological root, opening the door to modern psychiatric medicine.
Imipramine was discovered by accident. Swiss chemist Roland Kuhn was testing compounds for schizophrenia when he noticed patients on one of them—Imipramine—felt more energetic, less hopeless. He didn’t set out to treat depression, but he stumbled onto something revolutionary. By 1958, it was approved in Europe, and soon after in the U.S. It became the blueprint for dozens of other tricyclic antidepressants, a class of drugs that block the reuptake of serotonin and norepinephrine in the brain. Drugs like amitriptyline, nortriptyline, and desipramine all followed its lead. These weren’t just copies—they were improvements, each tweaked to reduce side effects or target specific symptoms. But Imipramine remained the gold standard for comparison.
It wasn’t perfect. Imipramine could cause dry mouth, dizziness, weight gain, and even heart rhythm issues in high doses. Many patients quit because of these side effects. But for those who didn’t respond to anything else, it was a lifeline. In the 1970s and 80s, it was one of the most prescribed antidepressants in the world. Even today, it’s still used—especially in cases of treatment-resistant depression, bedwetting in children, and chronic pain. Its role has shifted from first-line to fallback, but its impact hasn’t faded.
Behind every modern antidepressant is a story. Imipramine’s story is the foundation. It taught us that chemicals in the brain affect mood, that depression can be treated with medicine, and that discovery doesn’t always come from a hypothesis—it can come from watching a patient get better when no one expected it. The posts you’ll find here dive into the real-world use of Imipramine, its side effects, how it compares to newer drugs, and why some patients still rely on it decades after its debut. You’ll see how it fits into today’s treatment landscape, what research says about its long-term use, and how it shaped the way we think about mental health care today.
A deep dive into imipramine's discovery, FDA approval, clinical impact, and why it still matters in modern psychiatry.
A practical, side‑by‑side comparison of Aromasin (exemestane) with letrozole, anastrozole, and tamoxifen, covering mechanisms, side effects, cost, and choosing the right drug.
SGLT2 inhibitors like Jardiance and Farxiga lower blood sugar while protecting the heart and kidneys. Learn how they work, who benefits most, and what side effects to watch for.
Cholinergic urticaria causes itchy heat-induced hives when your body warms up. Learn what triggers it, how to prevent flare-ups, and what treatments actually work based on current medical research.
Hidradenitis suppurativa causes painful, recurring nodules that can lead to scarring and chronic pain. Biologic therapies like adalimumab, secukinumab, and bimekizumab now offer real relief by targeting inflammation at its source-changing the lives of thousands.
Tinnitus affects 1 in 5 people and is often linked to hearing loss. Learn the real causes, what actually helps - from hearing aids to CBT - and what to avoid. No magic cures, just science-backed strategies.